Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer (RELAY): Phase Ib Results
- Reck, M.
- Garon, E.B.
- Paz-Ares, L.
- Ponce, S.
- Jaime, J.C.
- Juan, O.
- Nadal, E.
- Kiura, K.
- Widau, R.C.
- He, S.
- Dalal, R.
- Lee, P.
- Nakagawa, K.
ISSN: 1938-0690, 1525-7304
Year of publication: 2018
Volume: 19
Issue: 3
Pages: 213-220.e4
Type: Article